SYRENIRING

This brand name is authorized in UK.

Active ingredients

The drug SYRENIRING contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII 423D2T571U - ETHINYL ESTRADIOL
 

Ethinylestradiol is chemically and biologically identical to endogenous human oestradiol. It substitutes for the loss of estrogen production in menopausal women, and alleviates menopausal symptoms. Estrogens prevent bone loss following menopause or ovariectomy.

 
Read more about 17 alpha-Ethinylestradiol
2
UNII 304GTH6RNH - ETONOGESTREL
 

Etonogestrel is the biologically active metabolite of desogestrel, a progestagen widely used in OCs. It is structurally derived from 19-nortestosterone and binds with high affinity to progesterone receptors in the target organs. The contraceptive effect of etonogestrel is primarily achieved by inhibition of ovulation.

 
Read more about Etonogestrel

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
GB Medicines & Healthcare Products Regulatory Agency 366023

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.